Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
Pharma
Novo Nordisk to slash prices of Fiasp, Tresiba in 2026
After slashing U.S. prices of several of its insulin products this year, Novo Nordisk has revealed similar price reductions for its other insulins.
Kevin Dunleavy
Dec 6, 2024 11:44am
Sanofi blueprints €1B insulin production hub in Beijing
Dec 2, 2024 10:50am
Novo to gradually phase out production of human insulin pens
Nov 14, 2024 2:13pm
Novo won't file for IcoSema approval in US
Aug 13, 2024 1:40pm
Sanofi will spend €1.3B to build new German insulin plant
Aug 1, 2024 8:51am
Following Lilly's lead, Sanofi inks Minnesota insulin settlement
Jul 24, 2024 11:25am
